FDA Approves First Biosimilar to Treat Multiple Sclerosis
U.S. Food and Drug Administration
Tyruko® has been shown to safely mitigate and manage inflammation in autoimmune conditions like Crohn’s disease
Tyruko® has been shown to safely mitigate and manage inflammation in autoimmune conditions like Crohn’s disease
Multicenter clinical trials demonstrated the efficacy of Zurzuvae in women with PPD